[HTML][HTML] Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

J Soppert, M Lehrke, N Marx, J Jankowski… - Advanced drug delivery …, 2020 - Elsevier
With cardiovascular disease being the leading cause of morbidity and mortality worldwide,
effective and cost-efficient therapies to reduce cardiovascular risk are highly needed. Lipids …

New ideas about atrial fibrillation 50 years on

S Nattel - Nature, 2002 - nature.com
Atrial fibrillation is a condition in which control of heart rhythm is taken away from the normal
sinus node pacemaker by rapid activity in different areas within the upper chambers (atria) of …

Cardiac hypertrophy: the good, the bad, and the ugly

N Frey, EN Olson - Annual review of physiology, 2003 - annualreviews.org
▪ Abstract Cardiac hypertrophy is the heart's response to a variety of extrinsic and intrinsic
stimuli that impose increased biomechanical stress. While hypertrophy can eventually …

Hypertrophy of the heart: a new therapeutic target?

N Frey, HA Katus, EN Olson, JA Hill - Circulation, 2004 - Am Heart Assoc
Recent studies call into question the necessity of hypertrophic growth of the heart as a
“compensatory” response to hemodynamic stress. These findings, coupled with recent …

[HTML][HTML] The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

OF Bueno, LJ De Windt, KM Tymitz, SA Witt… - The EMBO …, 2000 - embopress.org
Members of the mitogen‐activated protein kinase (MAPK) cascade such as extracellular
signal‐regulated kinase (ERK), c‐Jun N‐terminal kinase (JNK) and p38 are implicated as …

Cytoplasmic signaling pathways that regulate cardiac hypertrophy

JD Molkentin, GW Dorn II - Annual review of physiology, 2001 - annualreviews.org
▪ Abstract This review discusses the rapidly progressing field of cardiomyocyte signal
transduction and the regulation of the hypertrophic response. When stimulated by a wide …

GATA transcription factors in the developing and adult heart

S Pikkarainen, H Tokola, R Kerkelä… - Cardiovascular …, 2004 - academic.oup.com
During the past decade, emerging evidence has accumulated of different nuclear
transcription factors in regulation of cardiac development and growth as well as in cardiac …

Signaling pathways in cardiac myocyte apoptosis

P Xia, Y Liu, Z Cheng - BioMed research international, 2016 - Wiley Online Library
Cardiovascular diseases, the number 1 cause of death worldwide, are frequently associated
with apoptotic death of cardiac myocytes. Since cardiomyocyte apoptosis is a highly …

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

M Takemoto, K Node, H Nakagami… - The Journal of …, 2001 - Am Soc Clin Investig
Cardiac hypertrophy is a major cause of morbidity and mortality worldwide. The hypertrophic
process is mediated, in part, by small G proteins of the Rho family. We hypothesized that …

Molecular regulation of cardiac hypertrophy

SP Barry, SM Davidson, PA Townsend - The international journal of …, 2008 - Elsevier
Heart failure is one of the leading causes of mortality in the western world and encompasses
a wide spectrum of cardiac pathologies. When the heart experiences extended periods of …